Oncologist at the Euroonco clinic, PhD Roman Evstratov, shared his experience with artificial intelligence in medicine in an interview with RT.
“Thanks to accelerated computational processing, AI increases the throughput of research methods, and also helps to obtain better diagnostic images,” Evstratov said.
According to him, these factors contribute to a more accurate assessment of the volume and structure of the tumor, its relationship with surrounding tissues and tracking of multiple lesions.
“Moreover, AI is developing non-invasive diagnostic methods, allowing the patient to be examined without violating the integrity of the body. Another important aspect of the use of AI in oncology is risk stratification, ”the interlocutor of RT emphasized.
By analyzing clinical data, anamnesis, diagnostic images and histological findings, neural networks can determine the level of risk of developing a tumor and the likelihood of its progression.
“This allows us to more accurately determine the treatment plan and predict the results of therapy. In addition, AI can provide valuable data for predicting patient survival and determining the effectiveness of immunotherapy. With the help of medical imaging and data processing algorithms, AI can predict a possible response to therapy even before it starts, ”the expert explained.
The doctor also shared his experience with the advanced video dermatoscopy device FotoFinder. It allows you to create a so-called map of moles and track the dynamics of their changes.
“The doctor uses the machine to scan the body and obtain detailed microimages of all moles. This makes it possible to thoroughly study skin neoplasms and identify suspicious moles – with broken symmetry and uneven edges. The device is almost indispensable for mapping – tracking the growth dynamics and changes in moles. A year or two after the first scan, you can repeat the procedure and see if the moles have changed, if there are signs of pathology, ”the doctor explained.
According to him, the device is very useful for non-specialist doctors who are not associated with dermatoscopy and cannot work with an analog device.
“Such devices could be of great help in remote parts of our country, where there are no doctors with experience in dermatoscopy. They would help doctors correctly determine the nature of the neoplasm and suggest a further strategy of action: send it for removal or a biopsy, ”summed up Evstratov.
Earlier, Pavel Koposov, MD, oncologist, deputy director of the Institute of Oncology of the European Medical Center (EMC), in an interview with RT, advised people over 45 to be examined regularly.